Epigenetic escape of immunosurveillance by malignant cell precursors
The EMBO Journal · 2023
DOI: 10.15252/embj.2023114050 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, 2023. Verfasst von Claudia Galassi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Newly formed malignant cells must escape immunosurveillance to generate progressing neoplastic lesions of clinical relevance. Recent data indicate that the immunogenicity of nascent cancer cells, at least in some settings, is dictated by inherent epigenetic mechanisms rather than by immunoediting and the consequent Darwinian selection of poorly immunogenic phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
- Sandra and Edward Meyer Cancer Center, New York, NY, USA.
- Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA.
ORCID-Profile: Lorenzo Galluzzi
Zitieren
APA
Galassi, C., & Galluzzi, L. (2023). Epigenetic escape of immunosurveillance by malignant cell precursors. The EMBO Journal. https://doi.org/10.15252/embj.2023114050
Vancouver
Galassi C, Galluzzi L. Epigenetic escape of immunosurveillance by malignant cell precursors. The EMBO Journal. 2023. doi:10.15252/embj.2023114050
BibTeX
@article{Galassi2023,
author = {Galassi, Claudia and Galluzzi, Lorenzo},
title = {Epigenetic escape of immunosurveillance by malignant cell precursors},
journal = {The EMBO Journal},
year = {2023},
doi = {10.15252/embj.2023114050}
}
EUVIMED